Literature DB >> 17850377

The retroperitoneal laparoscopic Hellström technique for pelvi-ureteric junction obstruction from a crossing vessel.

Xu Zhang1, Kai Xu, Bin Fu, Jun Zhang, Bin Lang, Xing Ai, Baojun Wang, Taoping Shi, Xin Ma.   

Abstract

OBJECTIVE: To report our experience with the treatment of pelvi-ureteric junction obstruction (PUJO) using the retroperitoneal laparoscopic Hellström (RLH) technique to relocate the crossing vessel. PATIENTS AND METHODS: We used the RLH technique selectively in eight patients with PUJO from an aberrant crossing vessel, according to observations during surgery. The crossing vessel was mobilized and embedded in the generous pelvic wall with 4-0 polyglactin sutures to relieve the PUJO. Follow-up studies included intravenous urography, ultrasonography and renal functional scintigraphy at 1 month after surgery and every 3 months thereafter.
RESULTS: The mean (range) operative duration was 45 (40-60) min; the blood loss was negligible. Crossing vessels were identified to be anterior to the renal pelvis in two patients and posterior in six. The hospital stay after surgery was 5 (4-7) days. No paregoric was required after surgery. The collecting systems were intact and no JJ stent was required in any patient. The mean (range) follow-up was 13.6 (12-15) months. In all patients the obstruction was resolved or significantly improved, and there were no complications, e.g. urine leakage and infection. A long-term follow-up is mandatory.
CONCLUSIONS: The RLH technique is a minimally invasive alternative for patients with PUJO caused by a crossing vessel. Embedding the crossing vessels in the pelvic wall is feasible and safe for such patients; empirical judgement during surgery is prudent for success.

Entities:  

Mesh:

Year:  2007        PMID: 17850377     DOI: 10.1111/j.1464-410X.2007.07131.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Magnetic resonance urography and laparoscopy in paediatric urology: a case series.

Authors:  Maria Beatrice Damasio; Sara Costanzo; Emilio Podestà; Gianmarco Ghiggeri; Giorgio Piaggio; Fabio Faranda; Maria Ludovica Degl'Innocenti; Vincenzo Jasonni; Gian Michele Magnano; Piero Buffa; Giovanni Montobbio; Girolamo Mattioli
Journal:  Pediatr Radiol       Date:  2013-07-31

Review 2.  Pelvi-ureteric junction obstruction related to crossing vessels: vascular anatomic variations and implication for surgical approaches.

Authors:  Frédéric Panthier; Fabien Lareyre; Marie Audouin; Juliette Raffort
Journal:  Int Urol Nephrol       Date:  2018-01-04       Impact factor: 2.370

3.  Accessory or additional renal arteries show no relevant effects on the width of the upper urinary tract: a 64-slice multidetector CT study in 1072 patients with 2132 kidneys.

Authors:  B Glodny; K Rapf; V Unterholzner; P Rehder; K J Hofmann; A Strasak; R Herwig; J Petersen
Journal:  Br J Radiol       Date:  2010-03-11       Impact factor: 3.039

4.  Laparoscopic vascular relocation: alternative treatment for renovascular hydronephrosis in children.

Authors:  R R Singh; K K Govindarajan; H Chandran
Journal:  Pediatr Surg Int       Date:  2010-05-29       Impact factor: 1.827

5.  Pelviureteric Junction Obstruction Due to Vascular Anomalies in Children - Simple Surgical Options.

Authors:  Neehar Patil; Attibele Mahadevaiah Shubha; Kanishka Das
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-05-12

6.  Crossing vessels with suspension versus transposition in laparoscopic pyeloplasty of patients with ureteropelvic junction obstruction: a retrospective study.

Authors:  Jun Liu; Jingjun Zhang; Weinan Chen; Liulin Xiong; Xiaobo Huang; Xiongjun Ye
Journal:  BMC Urol       Date:  2021-05-06       Impact factor: 2.264

7.  Transposition and fixation of lower pole crossing vessel in children with ureteropelvic junction obstruction: A STROBE-compliant study.

Authors:  Vladimir V Sizonov; Askhab H-A Shidaev; Johannes M Mayr; Mikhail I Kogan; Ilya M Kagantsov; Vera V Rostovskaya
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.